Skip to main content
. Author manuscript; available in PMC: 2020 Mar 28.
Published in final edited form as: Nanoscale. 2019 Mar 28;11(13):6192–6205. doi: 10.1039/c8nr08970a

Table 1:

Average cell viability (All four cell lines) comparison between the non-transferrin and transferrin conjugated samples at their lowest concentrations. All the abbreviations are as below, C-dots-epirubicin (C-dots-epi), C-dots-temozolomide (C-dots-temo), C-dots-epirubicin+temozolomide (C-dots-epi+temo), C-dots-transferrin-temozolomide (C-TT), C-dots-transferrin-epirubicin (C-dots-epi), C-dots-transferrin-epirubicin-temozolomide (C-DT)

Concentration (μM) Average cell viability (%) of the cell lines SJGBM2, CHLA266, CHLA200, U87
Without Transferrin With Transferrin
C-dots-temo C-dots-epi C-dots-temo+epi C-TT C-ET C-DT
10.0 98.20 23.20 13.50 - - -
1.0 99.12 77.27 45.6 - - -
0.1 96.12 90.65 80.5 86.60 24.30 11.60
0.05 - - - 91.20 36.20 27.40
0.01 - - - 95.90 61.15 43.55